Atria Investments Inc Reduces Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Atria Investments Inc reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 15.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,700 shares of the financial services provider’s stock after selling 315 shares during the period. Atria Investments Inc’s holdings in iShares Biotechnology ETF were worth $248,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Jane Street Group LLC purchased a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at about $14,386,000. Cetera Investment Advisers boosted its position in shares of iShares Biotechnology ETF by 689.4% in the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after purchasing an additional 79,541 shares during the period. State of Michigan Retirement System increased its stake in shares of iShares Biotechnology ETF by 150.0% in the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after purchasing an additional 75,000 shares in the last quarter. Aristides Capital LLC bought a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at $9,180,000. Finally, Sanctuary Advisors LLC purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $8,118,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Up 1.4 %

Shares of iShares Biotechnology ETF stock opened at $137.96 on Friday. iShares Biotechnology ETF has a fifty-two week low of $117.28 and a fifty-two week high of $150.57. The company has a fifty day moving average of $143.43 and a 200 day moving average of $141.81.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.